{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T18:23:08Z","timestamp":1648837388805},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,7,9]],"date-time":"2014-07-09T00:00:00Z","timestamp":1404864000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1007\/s12013-014-0082-6","type":"journal-article","created":{"date-parts":[[2014,8,21]],"date-time":"2014-08-21T15:29:30Z","timestamp":1408634970000},"page":"1453-1457","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effects of Tumor Necrosis Factor Inhibitor on Serum Level of HLA-B27 and PDCD-1 in Patients with Ankylosing Spondylitis"],"prefix":"10.1007","volume":"70","author":[{"given":"Xiaogang","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinshan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaowu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junsheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,7,9]]},"reference":[{"issue":"3","key":"82_CR1","first-page":"613","volume":"27","author":"A Zink","year":"2000","unstructured":"Zink, A., Braun, J., Listing, J., & Wollenhaupt, J. (2000). Disability and handicap in rheumatoid arthritis and ankylosing spondylitis-results from the German rheumatological database. German Collaborative Arthritis Centers. The Journal of Rheumatology, 27(3), 613\u2013622.","journal-title":"The Journal of Rheumatology"},{"issue":"1","key":"82_CR2","first-page":"e4242","volume":"11","author":"A Rostamian","year":"2014","unstructured":"Rostamian, A., Mazoochy, H., Movassaghi, S., Mortazavi, S. M., Sadeghzadeh, E., Shahbazi, F., et al. (2014). Coexistence of ankylosing spondylitis and hereditary multiple exostoses: Coincidence or association. Iranian Journal of Radiology, 11(1), e4242.","journal-title":"Iranian Journal of Radiology"},{"key":"82_CR3","author":"A Tekatas","year":"2014","unstructured":"Tekatas, A., & Pamuk, O. N. (2014). Increased frequency of restless leg syndrome in patients with ankylosing spondylitis. International Journal of Rheumatic Diseases,. doi: 10.1111\/1756-185X.12323 .","journal-title":"International Journal of Rheumatic Diseases"},{"issue":"1","key":"82_CR4","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/1529-0131(199801)41:1<58::AID-ART8>3.0.CO;2-G","volume":"41","author":"J Braun","year":"1998","unstructured":"Braun, J., Bollow, M., Remlinger, G., Eggens, U., Rudwaleit, M., Distler, A., et al. (1998). Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. Arthritis and Rheumatism, 41(1), 58\u201367.","journal-title":"Arthritis and Rheumatism"},{"issue":"3","key":"82_CR5","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/ard.60.3.199","volume":"60","author":"A Zink","year":"2001","unstructured":"Zink, A., Listing, J., Klindworth, C., & Zeidler, H. (2001). The national database of the German Collaborative Arthritis Centres: I. Structure, aims, and patients. Annals of the Rheumatic Diseases, 60(3), 199\u2013206.","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"4","key":"82_CR6","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1136\/ard.2009.114397","volume":"69","author":"PT Yang","year":"2010","unstructured":"Yang, P. T., Xiao, W. G., Qin, L., Zhao, L. J., He, L. M., & Ito, M. (2010). A pilot study on changes of macrophage colony stimulating factor and transforming growth factor beta1 in male patients with ankylosing spondylitis taking thalidomide. Annals of the Rheumatic Diseases, 69(4), 781\u2013782.","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"6","key":"82_CR7","first-page":"1125","volume":"3","author":"WP Maksymowych","year":"2007","unstructured":"Maksymowych, W. P. (2007). Update on the treatment of ankylosing spondylitis. Therapeutics and Clinical Risk Management, 3(6), 1125\u20131133.","journal-title":"Therapeutics and Clinical Risk Management"},{"key":"82_CR8","unstructured":"Feng XH, Jiang Q, Liu HX, Wang HL, He XX, Zhang HD, Tang XP, Xu FQ, Liu J, Zhou CY et al [Clinical effect analysis of ankylosing spondylitis treated by Chinese medical syndrome differentiation]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi\u00a0=\u00a0Chinese Journal of Integrated Traditional and Western Medicine\/Zhongguo Zhong xi yi jie he xue hui, Zhongguo Zhong yi yan jiu yuan zhu ban 2013, 33(10):1309\u20131314."},{"issue":"4","key":"82_CR9","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/01.bor.0000163194.48723.64","volume":"17","author":"J Zochling","year":"2005","unstructured":"Zochling, J., & Braun, J. (2005). Management and treatment of ankylosing spondylitis. Current Opinion in Rheumatology, 17(4), 418\u2013425.","journal-title":"Current Opinion in Rheumatology"},{"issue":"1","key":"82_CR10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00393-012-1071-z","volume":"72","author":"U Kiltz","year":"2013","unstructured":"Kiltz, U., Sieper, J., & Braun, J. (2013). ASAS\/EULAR recommendations for the management of ankylosing spondylitis: Evaluation of the 2010 update in the German-speaking area. Zeitschrift fur Rheumatologie, 72(1), 71\u201380.","journal-title":"Zeitschrift fur Rheumatologie"},{"issue":"3","key":"82_CR11","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1590\/S0482-50042013000300003","volume":"53","author":"PD Sampaio-Barros","year":"2013","unstructured":"Sampaio-Barros, P. D., Keiserman, M., Meirelles Ede, S., Pinheiro Mde, M., Ximenes, A. C., Azevedo, V. F., et al. (2013). Recommendations for the management and treatment of ankylosing spondylitis. Revista Brasileira de Reumatologia, 53(3), 242\u2013257.","journal-title":"Revista Brasileira de Reumatologia"},{"issue":"6","key":"82_CR12","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1756-185X.2012.01817.x","volume":"15","author":"M Can","year":"2012","unstructured":"Can, M., Aydin, S. Z., Nigdelioglu, A., Atagunduz, P., & Direskeneli, H. (2012). Conventional DMARD therapy (methotrexate\u2013sulphasalazine) may decrease the requirement of biologics in routine practice of ankylosing spondylitis patients: A real-life experience. International Journal of Rheumatic Diseases, 15(6), 526\u2013530.","journal-title":"International Journal of Rheumatic Diseases"},{"issue":"6","key":"82_CR13","first-page":"850","volume":"30","author":"JA Miranda-Filloy","year":"2012","unstructured":"Miranda-Filloy, J. A., Llorca, J., Carnero-Lopez, B., Gonzalez-Juanatey, C., Blanco, R., & Gonzalez-Gay, M. A. (2012). TNF-alpha antagonist therapy improves insulin sensitivity in non-diabetic ankylosing spondylitis patients. Clinical and Experimental Rheumatology, 30(6), 850\u2013855.","journal-title":"Clinical and Experimental Rheumatology"},{"key":"82_CR14","doi-asserted-by":"crossref","first-page":"312647","DOI":"10.1155\/2014\/312647","volume":"2014","author":"I Voloshyna","year":"2014","unstructured":"Voloshyna, I., Seshadri, S., Anwar, K., Littlefield, M. J., Belilos, E., Carsons, S. E., et al. (2014). Infliximab reverses suppression of cholesterol efflux proteins by TNF-alpha: A possible mechanism for modulation of atherogenesis. BioMed Research International, 2014, 312647.","journal-title":"BioMed Research International"},{"issue":"Suppl 2","key":"82_CR15","doi-asserted-by":"crossref","first-page":"ii2","DOI":"10.1136\/annrheumdis-2013-203348","volume":"72","author":"DE Furst","year":"2013","unstructured":"Furst, D. E., Keystone, E. C., So, A. K., Braun, J., Breedveld, F. C., Burmester, G. R., et al. (2013). Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2012. Annals of the Rheumatic Diseases, 72(Suppl 2), ii2\u201334.","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"9","key":"82_CR16","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/rheumatology\/keh205","volume":"43","author":"J Braun","year":"2004","unstructured":"Braun, J., & Sieper, J. (2004). Biological therapies in the spondyloarthritis: the current state. Rheumatology (Oxford), 43(9), 1072\u20131084.","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"82_CR17","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/art.24001","volume":"59","author":"J Braun","year":"2008","unstructured":"Braun, J., Deodhar, A., Dijkmans, B., Geusens, P., Sieper, J., Williamson, P., et al. (2008). Efficacy and safety of infliximab in patients with ankylosing spondylitis over a two-year period. Arthritis and Rheumatism, 59(9), 1270\u20131278.","journal-title":"Arthritis and Rheumatism"},{"issue":"8","key":"82_CR18","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/ng.873","volume":"43","author":"DM Evans","year":"2011","unstructured":"Evans, D. M., Spencer, C. C., Pointon, J. J., Su, Z., Harvey, D., Kochan, G., et al. (2011). Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nature Genetics, 43(8), 761\u2013767.","journal-title":"Nature Genetics"},{"issue":"1","key":"82_CR19","first-page":"16","volume":"42","author":"MY Li","year":"2011","unstructured":"Li, M. Y., Yao, Z. Q., & Liu, X. Y. (2011). Advance of research on HLA-B27 and the immunological mechanism of ankylosing spondylitis. Sheng li ke xue jin zhan [Progress in Physiology], 42(1), 16\u201320.","journal-title":"Sheng li ke xue jin zhan [Progress in Physiology]"},{"key":"82_CR20","first-page":"171573","volume":"2013","author":"X Gu","year":"2013","unstructured":"Gu, X., Wu, H., & Fu, P. (2013). Allicin attenuates inflammation and suppresses HLA-B27 protein expression in ankylosing spondylitis mice. BioMed Research International, 2013, 171573.","journal-title":"BioMed Research International"},{"issue":"12","key":"82_CR21","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.3899\/jrheum.090341","volume":"36","author":"Z Wu","year":"2009","unstructured":"Wu, Z., Mou, Y., Lin, Z., Huang, J., Wei, Q., & Gu, J. (2009). HLA-B27 polymorphism in Han Chinese patients with ankylosing spondylitis: A distinctive disease association for B*2715 in a multiplex family. The Journal of Rheumatology, 36(12), 2849\u20132850.","journal-title":"The Journal of Rheumatology"},{"issue":"7809","key":"82_CR22","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S0140-6736(73)91360-3","volume":"1","author":"DA Brewerton","year":"1973","unstructured":"Brewerton, D. A., Hart, F. D., Nicholls, A., Caffrey, M., James, D. C., & Sturrock, R. D. (1973). Ankylosing spondylitis and HL-A 27. Lancet, 1(7809), 904\u2013907.","journal-title":"Lancet"},{"issue":"5","key":"82_CR23","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1089\/gtmb.2011.0183","volume":"16","author":"E Diyarbakir","year":"2012","unstructured":"Diyarbakir, E., Eyerci, N., Melikoglu, M., Topcu, A., & Pirim, I. (2012). HLA B27 subtype distribution among patients with ankylosing spondylitis in eastern Turkey. Genetic Testing and Molecular Biomarkers, 16(5), 456\u2013458.","journal-title":"Genetic Testing and Molecular Biomarkers"},{"issue":"4","key":"82_CR24","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1684\/ecn.2011.0293","volume":"22","author":"M Mahmoudi","year":"2011","unstructured":"Mahmoudi, M., Amirzargar, A. A., Jamshidi, A. R., Farhadi, E., Noori, S., Avraee, M., et al. (2011). Association of IL1R polymorphism with HLA-B27 positive in Iranian patients with ankylosing spondylitis. European Cytokine Network, 22(4), 175\u2013180.","journal-title":"European Cytokine Network"},{"issue":"20","key":"82_CR25","doi-asserted-by":"crossref","first-page":"5209","DOI":"10.1158\/0008-5472.CAN-12-1187","volume":"72","author":"W Peng","year":"2012","unstructured":"Peng, W., Liu, C., Xu, C., Lou, Y., Chen, J., Yang, Y., et al. (2012). PD-1 blockade enhances T-cell migration to tumors by elevating IFN-gamma inducible chemokines. Cancer Research, 72(20), 5209\u20135218.","journal-title":"Cancer Research"},{"issue":"5","key":"82_CR26","first-page":"763","volume":"29","author":"MT Tahoori","year":"2011","unstructured":"Tahoori, M. T., Pourfathollah, A. A., Akhlaghi, M., Daneshmandi, S., Nicknam, M. H., & Soleimanifar, N. (2011). Association of programmed cell death-1 (PDCD-1) gene polymorphisms with rheumatoid arthritis in Iranian patients. Clinical and Experimental Rheumatology, 29(5), 763\u2013767.","journal-title":"Clinical and Experimental Rheumatology"},{"key":"82_CR27","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1196\/annals.1375.043","volume":"1079","author":"Y Hiromine","year":"2006","unstructured":"Hiromine, Y., Ikegami, H., Fujisawa, T., Kawabata, Y., Noso, S., Yamaji, K., et al. (2006). Molecular scanning of the gene for programmed cell death-1 (PDCD-1) as a candidate for type 1 diabetes susceptibility. Annals of the New York Academy of Sciences, 1079, 285\u2013288.","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"12","key":"82_CR28","doi-asserted-by":"crossref","first-page":"e49698","DOI":"10.1371\/journal.pone.0049698","volume":"7","author":"JC Wei","year":"2012","unstructured":"Wei, J. C., Hung, K. S., Hsu, Y. W., Wong, R. H., Huang, C. H., Jan, M. S., et al. (2012). Genetic polymorphisms of stromal interaction molecule 1 associated with the erythrocyte sedimentation rate and C-reactive protein in HLA-B27 positive ankylosing spondylitis patients. PLoS ONE, 7(12), e49698.","journal-title":"PLoS ONE"},{"issue":"11","key":"82_CR29","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/art.24838","volume":"61","author":"MK Vries de","year":"2009","unstructured":"de Vries, M. K., van Eijk, I. C., van der Horst-Bruinsma, I. E., Peters, M. J., Nurmohamed, M. T., Dijkmans, B. A., et al. (2009). Erythrocyte sedimentation rate, C-reactive protein level, and serum amyloid a protein for patient selection and monitoring of anti-tumor necrosis factor treatment in ankylosing spondylitis. Arthritis and Rheumatism, 61(11), 1484\u20131490.","journal-title":"Arthritis and Rheumatism"},{"issue":"7","key":"82_CR30","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1136\/ard.2009.120139","volume":"69","author":"DA Poddubnyy","year":"2010","unstructured":"Poddubnyy, D. A., Rudwaleit, M., Listing, J., Braun, J., & Sieper, J. (2010). Comparison of a high sensitivity and standard C reactive protein measurement in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis. Annals of the Rheumatic Diseases, 69(7), 1338\u20131341.","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"3","key":"82_CR31","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1093\/rheumatology\/kep393","volume":"49","author":"M Benhamou","year":"2010","unstructured":"Benhamou, M., Gossec, L., & Dougados, M. (2010). Clinical relevance of C-reactive protein in ankylosing spondylitis and evaluation of the NSAIDs\/coxibs\u2019 treatment effect on C-reactive protein. Rheumatology (Oxford), 49(3), 536\u2013541.","journal-title":"Rheumatology (Oxford)"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-014-0082-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12013-014-0082-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-014-0082-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,23]],"date-time":"2020-08-23T15:14:44Z","timestamp":1598195684000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12013-014-0082-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,9]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["82"],"URL":"https:\/\/doi.org\/10.1007\/s12013-014-0082-6","relation":{},"ISSN":["1085-9195","1559-0283"],"issn-type":[{"value":"1085-9195","type":"print"},{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,9]]}}}